Neither BCBSA nor any local Blue company recommends, endorses, warrants or guarantees any specific Blue365 vendor or item
To emphasize just how serious all of this is, Eli Lilly, the manufacturer of Zepbound and Mounjaro, issued a direct warning to patients on their website about the dangers of compounded GLP-1s
Retatrutide is an investigational peptide-based medicine currently under clinical evaluation for the treatment of obesity and type 2 diabetes mellitus
United Healthcare, Cigna, Blue Cross Blue Shield, Aetna, Medicare, and Medicaid are some insurers that have provisions, often requiring prior authorization, especially for patients with a BMI of 30 or higher, or those with a BMI above 27 coupled with weight-related conditions
G., Huestis, M